ProNAi Therapeutics (United States)

Non-erythroid α-spectrin breakdown by calpain and interleukin 1 β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis

Rathna Nath, Kadee J. Raser, Daniel Stafford et al. · Biochemical Journal · 1996 · 426 citations · Full text

Kda Sbdp, Apoptosis, Immunology +23

Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention

Kengo Watanabe, Tomasz Wilmanski, Christian Diener et al. · Nature Medicine · 2023 · 125 citations · Full text

Dysbiosis, Genetic Epidemiology, Multiomics +22

Design, Synthesis, and Evaluation of Chromen-2-ones as Potent and Selective Human Dopamine D4 Antagonists

Suzanne R. Kesten, Thomas G. Heffner, Stephen J. Johnson et al. · Journal of Medicinal Chemistry · 1999 · 110 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Selective Affinity +15

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

Anthony W. Tolcher, Wendi V. Rodrigueza, Drew Rasco et al. · Cancer Chemotherapy and Pharmacology · 2013 · 87 citations · Full text

Formation of drug nanocrystals under nanoconfinement afforded by liposomes

David Cipolla, Hung‐Jen Wu, Stefan Salentinig et al. · RSC Advances · 2016 · 46 citations · Full text